Patent · US Active

Fast-off rate serum albumin binding fibronectin type III domains

US11434275B2 · kind B2 · utility

0Cited by

50References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Stanley Krystek · Ringoes, US
Tracy S. Mitchell · Andover, US
Michael L. Gosselin · Boston, US
Dasa Lipovsek · Pepperell, US
Juhi JUNEJA · Lexington, US

Key dates

Filing date	Jan 21, 2020
Grant date	Sep 6, 2022
Priority date	—
Expiry date	Jan 21, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2015/8518
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are polypeptides which include tenth fibronectin type III domains (10Fn3) that binds to serum albumin. Also provided are fusion molecules comprising a serum albumin binding 10Fn3 joined to a heterologous protein for use in diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.